Literature DB >> 36201054

Gastroenteropancreatic neuroendocrine neoplasm imaging: standard reporting templates.

Chadwick Barrs1, Malak Itani2, Maria Zulfiqar2, Joyce Mhlanga3,2, Isaac R Francis4, Ajaykumar Morani5, Priya Bhosale5, Motoyo Yano6, Amir Iravani7.   

Abstract

PURPOSE: Standardized reporting in radiology has an established role in numerous disease processes, with added benefits in oncology of reduced variability, and generation of a thorough and pertinent report with a focused and relevant conclusion. Many radiologists are not familiar with the imaging patterns of neuroendocrine neoplasm (NEN) spread and recurrence. This paper will present standardized CT, MRI, and PET templates for reporting gastroenteropancreatic (GEP) NENs and explain the rationale for including specific pertinent positive and negative findings, at various stages of disease management, based on site of origin.
METHODS: Basic templates for initial and follow-up anatomic and molecular GEP NEN imaging were created with input from the multidisciplinary Society of Abdominal Radiology (SAR) Neuroendocrine Tumor Disease Focused Panel (NET-DFP). The templates were further modified and finalized after several iterations.
RESULTS: Four main report templates were generated for (i) initial anatomic CT or MR imaging studies, (ii) follow-up anatomic CT or MR imaging studies, (iii) initial Somatostatin Receptor (SSTR) or FDG PET imaging studies, and (iv) follow-up SSTR or FDG PET imaging studies. Each study template was formatted to allow its integration into a dictation software directly and be modified as needed, with internalized instructions indicating where a drop-down menu or macro may be used to personalize the template as necessary.
CONCLUSION: These templates were created through a combination of multidisciplinary expert opinion discussion supported by literature review and provide basic structured reporting standards for GEP NEN anatomic and molecular imaging studies.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Neuroendocrine Neoplasms; Pancreatic; Structured reporting; Template

Year:  2022        PMID: 36201054     DOI: 10.1007/s00261-022-03677-0

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  3 in total

1.  Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide.

Authors:  E P Krenning; R Valkema; P P Kooij; W A Breeman; W H Bakker; W W deHerder; C H vanEijck; D J Kwekkeboom; M deJong; S Pauwels
Journal:  Ital J Gastroenterol Hepatol       Date:  1999-10

2.  Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.

Authors:  Arvind Dasari; Chan Shen; Daniel Halperin; Bo Zhao; Shouhao Zhou; Ying Xu; Tina Shih; James C Yao
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777

3.  Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.

Authors:  Zihan Xu; Li Wang; Shuang Dai; Mingjing Chen; Feng Li; Jianguo Sun; Feng Luo
Journal:  JAMA Netw Open       Date:  2021-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.